Organization
Rheumatology, University Hospital Maastricht, Maastricht, Netherlands
4 abstracts
Abstract
ASSESSING THE EFFICACY OF ANTI-TNF-ALPHA TREATMENT AS DISEASE MODIFYING OR DISEASE CONTROLLING THERAPY FOR PATIENTS WITH ANKYLOSING SPONDYLITISOrg: Rheumatology, University Hospital Maastricht, Maastricht, Netherlands,
Abstract
ASSESSMENT OF DISABILITY WITH THE WHODAS II IN PATIENTS WITH ANKYLOSING SPONDYLITISOrg: Rheumatology, University Hospital Maastricht, Maastricht, Netherlands,
Abstract
ADALIMUMAB TREATMENT MAINTAINS EFFICACY AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) – 2-YEAR RESULTS FROM ATLASOrg: Rheumatology, University Hospital Maastricht, Maastricht, Netherlands,
Abstract
ANTIBODIES AGAINST MUTATED CITRULLINATED VIMENTIN (MCV) ARE BETTER PREDICTORS OF RADIOGRAPHIC PROGRESSION THAN ANTIBODIES AGAINST CYCLIC CITRULLINATED PEPTIDES (CCP) Org: Rheumatology, Diakonhjemmet Hospital, Oslo, Immunology and Transfusion Medicine, University Hospital Ullevål, Oslo, Norway, Rheumatology, Leiden University Medical Center, Leiden, Netherlands, Rheumatology, University Hospital Maastricht, Maastricht, Netherlands,